Roy W Beck

75PUBLICATIONS
137CO-AUTHORS
Epidemiological modellingSustainable agricultural developmentAdolescent healthAutonomous agents and multiagent systemsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (75)

|Jun 23, 2026
Percent Time Below Range Is Strongly Associated with Clinically Important Level 2 Hypoglycemia Events in Individuals with Type 1 Diabetes.

|May 27, 2026
Letter: Treatment of Type 2 Diabetes in the United States: 2025.

|May 25, 2026
Raising the Bar: High Time in Range During the First Year of Diagnosis of Type 1 Diabetes in Children and Adolescents Using Automated Insulin Delivery with Intense Support.

|Dec 05, 2025
Automated Insulin Delivery Is Beneficial in Adults With Insulin-Treated Type 2 Diabetes With and Without GAD65 Antibodies.

Roy W Beck, Irl B Hirsch, Dan Raghinaru

|Nov 20, 2025
Additive Benefits of Control-IQ+ AID to GLP-1 Receptor Agonist Use in Adults With Type 2 Diabetes.

Timothy E Graham, Dan Raghinaru, Samina Afreen

|Nov 12, 2025
INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.

Michael J Haller, Lauren Kanapka, Roshanak Monzavi

Pageof 13

Frequent Collaborators

26 joint publications

Peter Calhoun

18 joint publications

Richard M Bergenstal

10 joint publications

Lauren Kanapka

9 joint publications

Irl B Hirsch